Colorectal Cancer
News and reporting on colorectal cancer.
Natera Builds Data Backing Serial ctDNA Changes to Aid CRC Patient Management, Treatment Decisions
Premium
The company believes its findings are the first to show that quantifying ctDNA changes can stratify high-risk colorectal cancer patients into better and worse prognostic groups.
Exact Sciences, NSABP Validating Ability of ctDNA Test to Detect MRD in Colorectal Cancer Patients
The study, called CORRECT-MRD II, is expected to enroll approximately 750 patients at 35 study sites in the US and Canada.
Natera Signatera Test to be Used in Study of MRD-Guided Treatment for Colon Cancer Patients
Patients will be randomized to receive various chemotherapy regimens depending on how Signatera identifies their minimal residual disease status.
Cell-Free DNA Can Help Predict Pathological Complete Response, Gauge Minimal Residual Disease
A suite of new studies examined how liquid biopsies could personalize treatment strategies in a range of cancer types.
Guardant Health Laying Path for Future in Cancer Screening, Updates Launch Plans for CRC Assay
Premium
The firm said it will release its colorectal cancer test as an LDT next year and has reorganized its leadership to support future growth in the cancer screening market.
Oct 30, 2018
Exact Sciences Q3 Revenues Up 63 Percent
Oct 30, 2018
Precision Oncology Highlights From ESMO 2018
Sep 27, 2018
Sep 6, 2018
Biocartis H1 2018 Revenues Jump 83 Percent
Aug 30, 2018
MDxHealth H1 Revenues Fall 29 Percent
Aug 28, 2018
Biocartis Licenses EGFR Ectodomain Mutations
Aug 22, 2018
Exact Sciences, Pfizer to Comarket Cologuard
Aug 1, 2018
Exact Sciences Q2 Revenues Up 78 Percent
Jun 14, 2018